New MS drug approved for use in the US

On 27 March, 2013, the US Food and Drug Administration (FDA) approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis.

Read more in the FDA press release | Read what the US National MS Society said about the news.